(m, 2H, –O–CH2CH2–), 1.64–1.45 (m, 2H, pyrz–CH2CH2–),
1.40 (m, 18H, other –CH2–).
1.6 Hz, 3-pyrz–H), 8.37 (d, 4H, J = 2.5 Hz, 6-pyrz–H), 8.08 (d,
8H, J = 8.6 Hz, 2-Ph–H) 7.25 (d, 8H, J = 8.6 Hz, 1-Ph–H), 4.23
(t, 8H, J = 6.6 Hz, Ph–OCH2–), 2.83 (t, 8H, J = 7.6 Hz, pyrz–
CH2–), 1.99–1.93 (m, 8H, PhOCH2–CH2–), 1.82–1.74 (m, 8H,
pyrz–CH2–CH2–), 1.64–1.57 [m, 8H, PhO(CH2)2–CH2–], 1.49–
1.38 [m, 32H, –CH2–(CH2)4–CH2–], −2.76 (brs, 2H, inner N–H).
HRMS (FAB): m/z 1494.8776 [M]+. Calc. for C96H110O4N12:
1494.8773 (D = +0.2 ppm). UV-Vis (CH2Cl2): kmax/nm (loge) 422
(5.54), 519 (4.10), 556 (3.97), 595 (3.59), 651 (3.67).
2-(30-Bromo-17-oxatricontane)pyrazine
2-(13-Hydroxyltridecananyl)pyrazine (133 mg, 0.48 mmol)
dissolved in THF (5 ml) was treated with NaH (60%, 100 mg)
under nitrogen, and was reacted with 1,16-dibromohexadecane
(371 mg, 0.97 mmol) in THF (3 ml) under reflux for 16 h. The
reaction mixture was quenched by methanol, and concentrated
under reduced pressure. The residue was dissolved in dichloro-
methane, washed with water, and dried over sodium sulfate. The
crude products were purified by silica-gel chromatography eluted
with hexane–diethyl ether (100/0 to 40/60) to afford 122 mg
Tetrakis[p-{17-(2-pyrazinyl)-n-heptadecanoxy}phenyl]porphyrin
(P17)
1
29%. H-NMR (500 MHz, CDCl3): d 8.84 (s, 8H, pyrrole–H),
1
(45%) of product. H-NMR (200 MHz, CDCl3): d 8.5–8.4 (m,
8.45 (dd, 4H, J = 1.4, 2.5 Hz, 5-pyrz–H), 8.42 (d, 4H, J =
1.4 Hz, 3-pyrz–H), 8.35 (d, 4H, J = 2.5 Hz, 6-pyrz–H), 8.09
(d, 8H, J = 8.5 Hz, 2-Ph–H), 7.26 (d, 8H, J = 8.5 Hz, 1-Ph–H),
4.23 (t, 8H, J = 6.5 Hz, Ph–OCH2–), 2.77 (t, 8H, J = 7.8 Hz,
pyrz–CH2–), 2.00–1.93 (m, 8H, PhOCH2–CH2–), 1.75–1.68
(m, 8H, pyrz–CH2–CH2–), 1.64–1.55 (m, 8H, –CH2–CH2–
CH2–), 1.49–1.42 (m, 8H, –CH2–CH2–CH2–), 1.42–1.23 [m,
88H, –(CH2)11–], −2.77 (brs, 2H, inner N–H); HRMS (FAB):
m/z 1943.3735 [M]+. Calc. for C128H174O4N12: 1943.3781
(D = −2.4 ppm). UV-Vis (CH2Cl2) kmax/nm (loge) 422 (5.54), 519
(4.11), 557 (3.98), 595 (3.60), 652 (3.76).
3H, pyrz–H), 3.5–3.3 (m, 6H, Br–CH2–, –CH2–O–CH2), 2.82 (t,
2H, J = 7.8 Hz, pyrz–CH2–), 1.86–1.11 (m, 48H, CH2).
2-(Bromomethyl)pyrazine
A solution of N-bromosuccinimide (3.78 g, 21.2 mmol),
AIBN (3.43 g, 20.9 mmol), and 2-methylpyrazine (2.00 g,
21.2 mmol) in benzene (15 ml) was refluxed for 1 h. After cool-
ing in an ice-bath, the mixture was filtered, and the solvent was
evaporated under reduced pressure. The residue was chromato-
graphed on silica-gel eluted with hexane/diethyl ether to afford
almost pure product, which was immediately used for the next
porphyrin synthesis since it was unstable at room temperature
Tetrakis[p-{30-(2-pyrazinyl)-17-oxatricontanoxy}phenyl]-
porphyrin (P30)
1
under air. H-NMR (200 MHz, CDCl3): d 8.71 (d, 1H, J =
1.4 Hz, 3-pyrz–H), 8.54 (dd, 1H, J = 1.4, 2.5 Hz, 5-pyrz–H),
8.49 (d, 1H, J = 2.5 Hz, 6-pyrz–H), 4.55 (s, 2H, –CH2–). MS
(EI): m/z 172, 174 [M]+.
Preparative HPLC (ODS) eluted with methanol followed by
recrystallization from dichloromethane/methanol gave 3.4 mg
(3%) product. H-NMR (500 MHz, CD2Cl2): d 8.93 (s, 8H,
1
pyrrole–H), 8.46 (dd, 4H, J = 1.5, 2.5 Hz, 5-pyrz–H), 8.44 (d,
4H, J = 1.5 Hz, 3-pyrz–H), 8.36 (d, 4H, J = 2.5 Hz, 6-pyrz–H),
8.14 (d, 8H, J = 6.5 Hz, 2-Ph–H), 7.33 (d, 8H, J = 6.5 Hz,
1-Ph–H), 4.30 (t, 8H, J = 6.5 Hz, Ph–OCH2–), 3.39–3.37 (m,
16H, –CH2–OCH2–), 2.80 (t, 8H, J = 7.8 Hz, pyrz–CH2–),
2.05–1.99 (m, 8H, PhOCH2–CH2–), 1.77–1.71 (m, 8H, pyrz–
CH2–CH2–), 1.70–1.64 (m, 8H, –CH2–CH2–CH2–), 1.58–1.23
(m, 176H, other –CH2–), −2.77 (brs, 2H, inner N–H); HRMS
(FAB): m/z 2680.1079 [M]+. Calc. for C176H270O8N12: 2680.1090
(D = −0.4 ppm). UV-Vis (CH2Cl2) kmax/nm (loge) 422 (5.60), 519
(4.16), 557 (4.04), 595 (3.67), 652 (3.77).
Tetrakis[p-{5-(2-pyrazinyl)-n-pentoxy}phenyl]porphyrin (P5)
A mixture of tetrakis(p-hydroxyphenyl)porphyrin (113.5 mg,
0.167 mmol), 2-(5-bromo-n-pentyl)pyrazine (475.8 mg,
2.08 mmol), K2CO3 (476.1 mg, 3.44 mmol), and 18-crown-6
(93.4 mg, 0.353 mmol) in DMF (10 ml) was stirred at 60 °C
under N2 overnight. The reaction mixture was cooled to room
temperature, and the solvent was evaporated under reduced
pressure. The residue was dissolved in CH2Cl2, washed with
water, and dried over sodium sulfate. Filtration, followed by
evaporation of the solvent gave a crude product as a black solid
which was twice purified by column chromatography on silica-
gel eluted with CH2Cl2/MeOH (100/0 to 95/5), and recrystallized
References
1
from CH2Cl2/MeOH to afford 108 mg (0.085 mmol, 51%). H-
1 J. Deisenhofer, O. Epp, K. Miki, R. Huber and H. Michel,
Nature, 1985, 318, 618; G. McDermott, S. M. Prince, A. A. Freer,
A. M. Hawthornthwaite-Lawless, M. Z. Papiz, R. J. Cogdell and
N. W. Isaacs, Nature, 1995, 374, 517; T. Pullerits and V. Sundstrom,
Acc. Chem. Res., 1996, 29, 381.
NMR (500 MHz, CDCl3): d 8.83 (s, 8H, pyrrole), 8.53–8.51 (m,
8H, 3 and 5-pyrz–H), 8.42 (d, 4H, J = 2.3 Hz, 6-pyrz–H), 8.08
(d, 8H, J = 8.1 Hz, 2-Ph–H) 7.24 (d, 8H, J = 8.1 Hz, 1-Ph–H),
4.25 (t, 8H, J = 6.0 Hz, Ph–OCH2–), 2.52 (t, 8H, J = 7.9 Hz,
pyrz–CH2–), 2.06–1.99 (m, 8H, PhOCH2–CH2–), 1.99–1.91 (m,
8H, PyCH2–CH2–), 1.79–1.68 (m, 8H, –CH2–CH2–CH2–), −2.77
(brs, 2H, inner N–H); HRMS (FAB): m/z 1270.6283 [M]+. Calc.
for C80H78O4N12: 1270.6269 (D = +1.1 ppm). UV-Vis (CH2Cl2):
kmax/nm (loge) 422 (5.62), 519 (4.15), 556 (4.01), 595 (3.64), 651
(3.70).
2 For examples of recent developments, see: M. Wasielewski, Chem.
Rev., 1992, 92, 435; D. Gust, T. A. Moore and A. L. Moore, Acc.
Chem. Res., 1993, 26, 198; H. Kurreck and M. Fuber, Angew.
Chem., Int. Ed. Engl., 1995, 34, 849; A. Harriman and J.-P. Sauvage,
Chem. Soc. Rev., 1996, 24, 41; V. Balzani, A. Juris, M. Venturi,
S. Champagna and S. Serroni, Chem. Rev., 1996, 96, 759; M.-J.
Blanco, M. C. Jiménez, J.-C. Chambron, V. Heitz, M. Linke
and J.-P. Sauvage, Chem. Soc. Rev., 1999, 28, 293; D. Gust,
T. A. Moore and A. L. Moore, Acc. Chem. Res., 2001, 34, 40;
M.d. R. Benitetes, T. E. Johnson, S. Weghorn, L. Yu, P. D. Rao,
J. R. Diers, S. I. Yang, C. Kimaier, D. F. Bocian, D. Holte and
J. S. Lindsey, J. Mater. Chem., 2002, 12, 65; V. Balzani, A. Credi,
M. Venturi, Molecular Devices and Machines – A Journey into the
Nano World, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim,
2003.
3 For recent reviews of the porphyrin assemblies, see: H. Ogoshi,
T. Mizutani, T. Hayashi and Y. Kuroda, in The Porphyrin Hand-
book. Vol.6, Applications: Past, Present and Future, K. M. Kadish,
K. M. Smith and R. Guilard, ed., Academic Press, New York,
2000, pp. 279–340; and A. K. Burell, D. L. Officer, P. G. Plieger
and D. C. W. Reid, Chem. Rev., 2001, 101, 2751. For examples of
trimeric or lager porphyrin assemblies, see: P. Tecilla, R. P. Dixon,
G. Slobodkin, D. S. Alavi, D. H. Waldeck and A. D. Hamilton,
J. Am. Chem. Soc., 1990, 112, 9408; A. M. Brun, S. J. Atherton,
A. Harriman, V. Heitz and J.-P. Sauvage, J. Am. Chem. Soc., 1992,
Tetrakis{p-(2-pyrazinyl)methoxyphenyl}porphyrin (P1)
1
9%. H-NMR (500 MHz, CDCl3): d 9.06 (d, 4H, J = 1.5 Hz,
3-pyrz–H), 8.84 (s, 8H, pyrrole–H), 8.66 (dd, 4H, J = 1.5,
2.4 Hz, 5-pyrz–H), 8.63 (d, 4H, J = 2.4 Hz, 6-pyrz–H), 8.14
(d, 8H, J = 8.2 Hz, Ph–H), 7.38 (d, 8H, J = 8.2 Hz, Ph–H),
5.33 (s, 8H, –CH2–), −2.79 (brs, 2H, inner N–H). HRMS
(FAB): m/z 1046.3771 [M]+. Calc. for C64H46O4N12: 1046.3765
(D = +0.6 ppm). UV-Vis (CH2Cl2): kmax/nm (loge) 421 (5.66), 518
(4.21), 554 (4.02), 595 (3.69), 650 (3.74).
Tetrakis[p-{9-(2-pyrazinyl)-n-nonoxy}phenyl]porphyrin (P9)
1
13%. H-NMR (500 MHz, CDCl3): d 8.84 (s, 8H, pyrrole–H),
8.48 (dd, 4H, J = 1.6, 2.5 Hz, 5-pyrz–H), 8.46 (d, 4H, J =
O r g . B i o m o l . C h e m . , 2 0 0 4 , 2 , 2 8 5 2 – 2 8 6 0
2 8 5 9